Robert Dreicer
- Surgery top 0.5%
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 5%
- Cancer Research top 1%
- Co-authors
- Brian I. RiniPaul ElsonRonald M. BukowskiLaura S. WoodBruce J. RothJorge A. GarcíaGuru SonpavdeMatthew D. Galsky
- Topics
- Renal cell carcinoma treatment (68 papers)Bladder and Urothelial Cancer Treatments (68 papers)Urinary and Genital Oncology Studies (41 papers)
- Partner nations
- United StatesSpainIndia
In The Last Decade
Robert Dreicer
178 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Surgery 3.8k
- Oncology 3.3k
- Pulmonary and Respiratory Medicine 2.9k
- Molecular Biology 2.3k
- Cancer Research 1.2k
Countries citing papers authored by Robert Dreicer
This map shows the geographic impact of Robert Dreicer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Dreicer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Dreicer more than expected).
Fields of papers citing papers by Robert Dreicer
This network shows the impact of papers produced by Robert Dreicer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Dreicer. The network helps show where Robert Dreicer may publish in the future.
Co-authorship network of co-authors of Robert Dreicer
This figure shows the co-authorship network connecting the top 25 collaborators of Robert Dreicer. A scholar is included among the top collaborators of Robert Dreicer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Dreicer. Robert Dreicer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 89 | |
| 2 | 22 | |
| 3 | 76 | |
| 4 | 7 | |
| 5 | 210 | |
| 6 | 83 | |
| 7 | Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patientsbreakdown → | 690 |
| 8 | 8 | |
| 9 | 10 | |
| 10 | 2 | |
| 11 | 283 | |
| 12 | 5 | |
| 13 | 11 | |
| 14 | 61 | |
| 15 | 23 | |
| 16 | 25 | |
| 17 | 398 | |
| 18 | 9 | |
| 19 | 155 | |
| 20 | 3 |
About Robert Dreicer
Robert Dreicer is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 179 papers that have together received 8.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (68 papers), Bladder and Urothelial Cancer Treatments (68 papers) and Urinary and Genital Oncology Studies (41 papers). The work is most often cited by research in Oncology (3.3k citations), Urology (671 citations) and Pulmonary and Respiratory Medicine (2.9k citations). Robert Dreicer has collaborated with scholars based in United States, Spain and India. Frequent co-authors include Brian I. Rini, Paul Elson, Ronald M. Bukowski, Laura S. Wood, Bruce J. Roth, Jorge A. García, Guru Sonpavde, Matthew D. Galsky, Joaquim Bellmunt and George Wilding. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.